Human Infection with H7N9 Virus
Overview
Authors
Affiliations
Dreier C, Resa-Infante P, Thiele S, Stanelle-Bertram S, Walendy-Gnirss K, Speiseder T Emerg Microbes Infect. 2019; 8(1):1324-1336.
PMID: 31503518 PMC: 6746284. DOI: 10.1080/22221751.2019.1663131.
Wang W, Erazo E, Chang Ishcol M, Lin C, Assavalapsakul W, Thitithanyanont A J Int Med Res. 2019; 48(1):300060519845488.
PMID: 31068040 PMC: 7140199. DOI: 10.1177/0300060519845488.
Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
Yang X, Zhao J, Wang C, Duan Y, Zhao Z, Chen R PLoS One. 2015; 10(4):e0123659.
PMID: 25884801 PMC: 4401572. DOI: 10.1371/journal.pone.0123659.
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury.
Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C Sci Rep. 2014; 4:7027.
PMID: 25391767 PMC: 4229671. DOI: 10.1038/srep07027.
Response of mice and ferrets to a monovalent influenza A (H7N9) split vaccine.
Duan Y, Gu H, Chen R, Zhao Z, Zhang L, Xing L PLoS One. 2014; 9(6):e99322.
PMID: 24937303 PMC: 4061005. DOI: 10.1371/journal.pone.0099322.